SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-046627
Filing Date
2021-02-17
Accepted
2021-02-17 17:01:50
Documents
15
Period of Report
2021-02-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d143034d8k.htm   iXBRL 8-K 26003
2 EX-99.1 d143034dex991.htm EX-99.1 243274
6 GRAPHIC g143034im1.jpg GRAPHIC 7537
7 GRAPHIC g143034im2.jpg GRAPHIC 3661
  Complete submission text file 0001193125-21-046627.txt   432797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210217.xsd EX-101.SCH 2718
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210217_lab.xml EX-101.LAB 18063
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210217_pre.xml EX-101.PRE 11361
8 EXTRACTED XBRL INSTANCE DOCUMENT d143034d8k_htm.xml XML 3444
Mailing Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2
Business Address 1100 MAUGHAN ROAD NANAIMO A1 V9X 1J2 2064329325
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 21645817
SIC: 2833 Medicinal Chemicals & Botanical Products